Important supply update – Aridol® (Mannitol)

ANZSRS and the Thoracic Society of Australia and New Zealand (TSANZ) are aware of current supply concerns affecting Aridol® (Mannitol), used by respiratory laboratories for bronchial provocation testing.

The Therapeutic Goods Administration has listed an anticipated shortage of Aridol®, with a supply impact period from 1 October 2026 to 31 December 2027.

ANZSRS and TSANZ are continuing to seek further clarification regarding ongoing supply and will provide further information to members as it becomes available.

View the Aridol® supply update

Help us understand bronchial provocation testing availability

To support laboratories and clinicians during this period, ANZSRS is also seeking information from respiratory laboratories regarding the bronchial provocation testing currently available at their service.

If your laboratory provides bronchial provocation testing, please complete our short form with the testing offered and relevant laboratory contact details.

Submit your laboratory details

This information will help ANZSRS better understand testing availability across Australia and New Zealand and assist with future communication to members.